Viewing StudyNCT00233909



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00233909
Status: COMPLETED
Last Update Posted: 2008-04-01
First Post: 2005-10-04

Brief Title: A Trial of Gemtuzumab Ozogamicin GO in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Sponsor: Kanisa Pharmaceuticals
Organization: Kanisa Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-10
Start Date Type: None
Primary Completion Date: 2008-03
Primary Completion Date Type: ACTUAL
Completion Date: 2008-03
Completion Date Type: ACTUAL
First Submit Date: 2005-10-04
First Submit QC Date: October 4 2005
Study First Post Date: 2005-10-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-03-28
Last Update Post Date: 2008-04-01
Last Update Post Date Type: ESTIMATED